Study Validates Use of Crescendo Bioscience’s Vectra™ DA Test as an Objective Measure of Rheumatoid Arthritis Disease Activity
12:02 EDT 26 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Crescendo
Bioscience®, Inc., a molecular diagnostics company, today
announced the online publication of results validating the performance
of Vectra™
DA to measure rheumatoid arthritis (RA) disease activity in Arthriti...
Other Sources for this Article
On behalf of Crescendo Bioscience
Edie DeVine, 415-365-8543
edie.devine@gcihealth.com
More From BioPortfolio on "Study Validates Use of Crescendo Bioscience’s Vectra™ DA Test as an Objective Measure of Rheumatoid Arthritis Disease Activity"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
